AI FOR BIOLOGY

Cancer
World Model

We’re an AI-for-biology startup building digital cancer models to predict cancer response, support personalized treatment research, and accelerate drug discovery.

Explore all three models

2 models available 1 in development

01 Universal model

Universal Cancer
World Model

Predict cancer response

The need

How does a cell’s starting state shape its response? Researchers need a way to connect molecular context, environmental conditions, and interventions within a shared model of cell behavior.

Expected outcome

Develop a clearer link between cell profiles and response. The current simulator lets you compare modeled behavior over time and frame questions for further experiments; its cellular dynamics remain illustrative.

02 Radiation model

Radiation
World Model

Support personalized treatment research

The need

Researchers need to connect cell-line biology with radiation damage, repair, and survival. Understanding these relationships can help frame questions about why different cellular contexts respond differently to the same exposure.

Expected outcome

Explore RNA-conditioned radiation response and inspect the evidence behind it. The fitted condition is a single 2 Gy exposure with an assumed 72-hour repair window; other doses and schedules remain exploratory.

03 Drug model

Drug Test
Model

Accelerate drug discovery

The need

Drug research needs to distinguish slowed cell division from cell killing, and connect these outcomes to molecular context and mechanism. A useful digital experiment should help explain which biological questions need laboratory testing.

Expected outcome

The ambition is to prioritize testable drug-response hypotheses and focus the next experiment. A dedicated Drug Test Model is in development; these planned capabilities are not yet available as a released model.

WHAT’S NEXT

Build better models.
Test them against biology.

Our next model direction is dedicated drug testing. Our longer-term goal is a shared cancer research platform with richer cell-line inputs and broader experimental evaluation.

We’re building toward the same three outcomes: understand cancer response, support personalized treatment research, and focus drug-discovery experiments.

Explore our latest release Research prototypes. Not intended for clinical diagnosis or treatment decisions.